Key result
Left ventricular expander lowers maximal LV pressure ~12% in simulated HFpEF models.
Why the study?
Although LV expanders have shown promising results in animals and humans, further evaluation was needed to assess a range of functions and risk of use.
Does a left ventricular expander reduce filling pressures and improve diastolic function in computational models of HFpEF?
Does a left ventricular expander reduce filling pressures and improve diastolic function in computational models of HFpEF?
Answers are grounded in this paper and cite their sources.
Computational simulation indicates that left ventricular expanders can safely decrease pathological filling pressures and improve compliance in hearts with HFpEF without compromising systolic pump function.
Increased cardiac stiffness hinders proper left ventricular (LV) expansion, resulting in decreased volume and diastolic dysfunction. LV expanders are spring-like devices designed to improve diastolic function by facilitating mechanical outward expansion. Implantations in animals and humans have shown promising results, yet further evaluation is needed to assess a range of functions and the risk of use. In this computational study, the effectiveness and potential use of a generic LV expander were assessed by using previously generated finite-element models of induced heart failure with preserved ejection fraction (HFpEF). Following implantation, the treated models were compared to the corresponding untreated and healthy pre-induction models. The influence of device orientation and its material properties was also examined. Our results demonstrated a reduction in LV pressure and a volumetric improvement. Computed LV stresses have shown no gross irregularities. The device contributed to stress elevation during diastole while having a minor effect during systole, supporting a basic safety profile. This is the first study to use numerical analysis to assess LV expanders' performance on different HFpEF phenotypes. Improvement in heart function was demonstrated in both subjects, suggesting its potential use in various HFpEF manifestations, yet customization and optimal deployment are essential to improve heart performance.
No takes yet. Share an insight, caveat, or question.
Weissmann et al. (2023) studied Heart failure with preserved ejection fraction (HFpEF) (n=2). Generic left ventricular expander vs. Untreated HFpEF model and healthy pre-induction model was evaluated on Left ventricular maximal pressure (11-13% reduction). In computational models of induced HFpEF, a left ventricular expander reduced maximal left ventricular pressure by 11% to 13% and improved volumetric expansion while maintaining preserved ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: